ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Bristol Myers Squibb

Bristol Myers Squibb (BRM)

56.03
0.00
(0.00%)
Closed November 27 3:00PM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
56.03
Bid
56.03
Ask
56.03
Volume
0.00
0.00 Day's Range 0.00
36.315 52 Week Range 58.32
Market Cap
Previous Close
56.03
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
7,988
Shares Outstanding
2,028,176,674
Dividend Yield
4.49%
PE Ratio
14.85
Earnings Per Share (EPS)
3.96
Revenue
45.01B
Net Profit
8.03B

About Bristol Myers Squibb

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Bristol Myers Squibb is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BRM. The last closing price for Bristol Myers Squibb was 56.03 €. Over the last year, Bristol Myers Squibb shares have traded in a share price range of 36.315 € to 58.32 €.

Bristol Myers Squibb currently has 2,028,176,674 shares outstanding. The market capitalization of Bristol Myers Squibb is 113.64 € billion. Bristol Myers Squibb has a price to earnings ratio (PE ratio) of 14.85.

BRM Latest News

TOP NEWS: Bristol-Myers beats on revenue but swings to quarterly loss

Bristol-Myers Squibb Co on Thursday reported a swing to a first-quarter loss on charges related to its acquisition of ...

Bristol-Myers inks USD380 million supply agreement with Cellares

Bristol-Myers Squibb on Monday said it has signed an agreement to expedite the manufacturing of its CAR-T cell therap ...

IN BRIEF: BMS adds to neuroscience portfolio with Karuna acquisition

ibb Co - New York-based pharmaceutical company - Completes acquisition of Karuna Therapeutics Inc, a Massachusetts-bas ...

TOP NEWS: Bristol-Myers quarterly revenue up as new products shine

Bristol-Myers Squibb Co on Friday reported stronger fourth-quarter revenue, with sales from new drug launches increas ...

Bristol-Myers gets EMA validation for lung-cancer drug, repotrectinib

Bristol-Myers Squibb Co on Tuesday announced that the European Medicines Agency had validated an application for a lu ...

TOP NEWS: Bristol-Myers makes second holiday acquisition with RayzeBio

Bristol-Myers Squibb Co on Tuesday announced its second large acquisition in four days, saying it has agreed to buy N ...

TOP NEWS: Bristol-Myers swoops for schizophrenia drugmaker Karuna

Bristol-Myers Squibb Co on Friday agreed to buy biopharmaceutical company Karuna Therapeutics Inc for USD14.0 billion ...

Leading pharmaceutical firms highlight positive trial data on lymphoma

A number of leading pharmaceutical companies on Monday reported positive trial results on the treatment of lymphoma, ...

Bristol-Myers Squibb to buy back extra USD3 billion shares

Drug maker Bristol-Myers Squibb Co on Thursday said it will repurchase another batch of its shares. It authorised a ...

IN BRIEF: Bristol-Myers Squibb receives approval for Abecma in Japan

ibb Co - Princeton, New Jersey-based pharmaceutical company - Receives manufacturing and marketing approval of the sup ...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.691.2468377303955.3457.3954.71630455.8869078DE
47.81516.208648760848.21558.3248.0451072653.6000989DE
1210.56523.237655339345.46558.3243.01798849.73866701DE
2617.8146.598639455838.2258.3236.3151031243.66290898DE
5210.5323.142857142945.558.3236.3151084144.17879548DE
1565.3510.556432517850.6880.536.315492148.40611698DE
2604.588.9018464528751.4580.536.315443050.06819808DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
013CJDcom Inc
16.748 €
(0.00%)
0
013AJD.com Inc
33.75 €
(0.00%)
0
0110Thesis Gold Inc
0.425 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
16.748 €
(0.00%)
0
013AJD.com Inc
33.75 €
(0.00%)
0
0110Thesis Gold Inc
0.425 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
16.748 €
(0.00%)
0
013AJD.com Inc
33.75 €
(0.00%)
0
0110Thesis Gold Inc
0.425 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0

Discussion

View Full Feed
BakedLangostino BakedLangostino 6 minutes ago
There is definitely going to be competition from all angles. My hope is that the Sigmar1 moat is fairly deep and will prevent enough direct competition until something better comes along, hopefully A371.

Ozempic may work well but if it restricts appetite in non-obese populations, I c
AVXL
Batman412 Batman412 7 minutes ago
It's a scummy company on the verge of bankruptcy 
TONR
Batman412 Batman412 8 minutes ago
They posted a pr saying Ai callers is division of bot makers before any share agreement or anything of the sort showing a connection 
TONR
Bright Boy Bright Boy 9 minutes ago
Without question, the best news I've heard in the 8 years I've been a shareholder in Northwest!!! Today, Judge Ho, Federal Judge in the Southern District of New York, allowed the Phunware case to survive the MTD and proceed to Discovery and Trial. This is the same district that the Northwest case i
NWBO
Batman412 Batman412 9 minutes ago
We've seen this the last few weeks but it doesn't move it's gonna take more than a few million to move it 
TONR
Viking61 Viking61 10 minutes ago
You’re absolutely right, Rick!!!!
FNMA
BakedLangostino BakedLangostino 15 minutes ago
Where did the Amazon rumor originate? Was that something that started on this forum or is there a transcript somewhere of Dr. Missling mentioning Amazon as a potential partner? Because the more I think about it, the more it makes sense.

1. It's would be a big splash for Amazon's fled
AVXL
E A E A 17 minutes ago
546 days since Timothy Holly took over as CEO. Still in expert market.

They’re trying to save our investments, I don’t see any red flags there

I SEE a 5.2 billion valuation…

There’s potential here. You haven’t done your hw
TTCM
dinogreeves dinogreeves 19 minutes ago
This is terrible

https://finance.yahoo.com/quote/PGHL/
SAVA
dinogreeves dinogreeves 20 minutes ago
Now look at this, now this what you call gamblers that will lose everything on nothing. Now, that is sad, truly sad. Only 13 million in revenues. 660,000 volume, where are the bag holders trapped from?

https://finance.yahoo.com/quote/PGHL/

https://finance.yahoo.com/
SMCI
RickNagra RickNagra 20 minutes ago
Wrong.  Look again carefully.  I recommend zooming in.  It says com and not con.
FNMA
BamaBreeze BamaBreeze 24 minutes ago
The management would stand to make A lot of money. More than cheating shareholders out of theirs. That would be a major incentive I would think.
BLLB
jondoeuk jondoeuk 25 minutes ago
A post on LinkedIn (by Alex Shih-Min Huang who is VP, Head of Cell Therapy at BGNE): 'Though our very first experiment was initiated only 2.5 years ago amidst ongoing laboratory construction and pandemic, fast forward to this day, we have already 1) generated a proprietary, well-characterized GMP gr
BGNE
gfp927z gfp927z 25 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
ACXP
dinogreeves dinogreeves 27 minutes ago
Analyst are going to scratch their heads tomorrow if there is no press release based on all the notes fully paid off, upwards of 2 billion dollars, if the numbers were cooked and there was going to be fraud charges against the company, they would have taken the money and ran, but instead they paid i
SMCI
bluebird50 bluebird50 27 minutes ago
Guess crows don't like coffee.... delete this post and Crows... 

;-) so we don't witness a murder... a group of crows... Che Che Che 
RDAR
BamaBreeze BamaBreeze 28 minutes ago
Good on you!! Bless us.
BLLB
ducci1 ducci1 28 minutes ago
Pivot Calcs: SPX Pivot--6012----R1--6033----R2--6045----S1--6000----S2--5980-----SPY Pivot--599----R1--601----R2--602----S1--598----S2--596-----VIX Pivot--14.33 !!LOL!!
VIX
imnot6 imnot6 28 minutes ago
Well, extended duration is their value proposition...
JohnnyHydrogen JohnnyHydrogen 29 minutes ago
AI Czar ?

https://www.axios.com/2024/11/26/trump-ai-czar-role-elon-musk

....

"The office would spur the massive private investment needed to expand the energy supply to keep the U.S. on the cutting edge."
FCEL
gfp927z gfp927z 30 minutes ago
Bigworld, Here's more info relating to Acurx's recent move to buy some Bitcoin (below). So far that boneheaded decision by Luci has cut Acurx's share price nearly in half -


Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000

gfp927z gfp927z 34 minutes ago
Acurx - >>> MicroStrategy Copycats Are Buying Bitcoin as Price Nears $100,000


Barron's

by Paul R. La Monica

Nov 22, 2024


https://www.barrons.com/articles/microstrategy-copycats-companies-buy-bitcoin-0032c5ff?siteid=yhoof2
Mountainman5 Mountainman5 34 minutes ago
Red Cat & OPT = WinWin!!!!!!!!!!!!!
OPTT
BDEZ BDEZ 36 minutes ago
Thanks georgie..
XRPUSD

Your Recent History

Delayed Upgrade Clock